ABIFLOX EFFICACY IN COMPLEX THERAPY OF PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
Journal: The Journal of V.N. Karazin Kharkiv National University, series "Medicine" (Vol.26, No. 26)Publication Date: 2013-12-30
Authors : Lyadova T. I.; Volobuyeva О. V.; Sevastyanova Т. V.; Savvo А. N.;
Page : 23-27
Keywords : community acquired pneumonia; antibiotic therapy; levofloxacin (Abiflox);
Abstract
The article presents the results of the study, during which the efficacy of levofloxacin in the treatment of patients with community-acquired pneumonia was evaluated. It was found that levofloxacin is a highly effective treatment for patients with community-acquired pneumonia.
Other Latest Articles
- MODERN DIRECTIONS OF HERPESVIRUS INFECTIONS PHARMACOTHERAPY
- SENSITIVITY TO ANTIBIOTICS AMONG STRAINS OF SALMONELLA CURRENT, WHICH CIRCULATES IN THE PAST 10 YEARS IN UKRAINE
- FROM PHYSIOLOGICAL TO PATHOLOGICAL METEOSENSITIVITY
- COMPLICATIONS AND FACTORS OF REACTIVATION OF VZV-INFECTION IN CHILDREN AND ADULTS
- EXPERIENCE OF MANAGEMENT OF THE PATIENT WITH THE RESYNCHRONIZATION BIVENTRICULAR PACING WITHOUT DESTRUCTION OF ATRIO-VENTRICULAR NODE SUFFERING FROM CHRONIC HEART FAILURE AND PERMANENT ATRIAL FIBRILLATION
Last modified: 2015-07-27 00:10:13